XML 110 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (Tables)
12 Months Ended
Jun. 30, 2013
SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION [Abstract]  
Schedule of Accounts Receivable
Accounts receivable:

 

    June 30,  
    2013     2012  
    ($ in thousands)  
1) Trade:                
Open accounts   $ 2,068     $ 2,039  
Allowance for doubtful accounts     (329 )     (215 )
    $ 1,739     $ 1,824  
2) Other:                
Due from government institutions   $ 176     $ 124  
Advance payments to suppliers     202       118  
Miscellaneous     10       22  
    $ 388     $ 264  
Schedule of Changes in Allowance for Doubtful Accounts

The changes in "Allowance for doubtful accounts" during the years ended June 30, 2013 and 2012 are as follows:

 

    Year ended June 30,  
    2013     2012  
    ($ in thousands)  
Balance at beginning of period   $ 215     $ 155  
Additions during the period     245       78  
Deductions during the period     (142 )        
Exchange rate differences     11       (18 )
Balance at end of period   $ 329     $ 215  
Schedule of Inventories
Inventories:

 

    June 30,  
    2013     2012  
    ($ in thousands)  
Finished goods   $ 364     $ 479  
Work in process     1,111       1,115  
Raw materials and supplies     118       150  
    $ 1,593     $ 1,744  
Schedule of Inventory on Consignment

The changes in inventory on consignment during the years ended June 30, 2013 and 2012 are as follows:

 

    Year ended June 30,  
    2013     2012  
    ($ in thousands)  
Balance at beginning of period   $ 63     $ 82  
Costs of revenues deferred during the period     20       63  
Costs of revenues recognized during the period     (83 )     (82 )
Balance at end of period   $ -     $ 63  
Schedule of Accounts Payable and Accruals
Accounts payable and accruals-other:

 

    June 30,  
    2013     2012  
    ($ in thousands)  
Employees and employee institutions   $ 626     $ 438  
Accrued vacation and recreation pay     313       272  
Accrued clinical trials expenses     513       607  
Provision for sales commissions     205       194  
Accrued expenses     1,343       1,197  
Due to government institutions     15       22  
Provision for returns             139  
Taxes payable     13       56  
    $ 3,028     $ 2,925  
Schedule of Deferred Revenues

The changes in deferred revenues during the years ending June 30, 2013 and 2012 are as follows:

 

    Year ended June 30,  
    2013     2012  
    ($ in thousands)  
Balance at beginning of period   $ 10     $ -  
Revenue deferred during the period             25  
Revenue recognized during the period             (15 )
Balance at end of period   $ 10     $ 10  
Schedule of Financial Expenses (Income), Net
Financial expenses, net:

 

    Year ended June 30,  
    2013     2012  
    ($ in thousands)  
Bank commissions   $ 38     $ 50  
Interest income     (28 )     (40 )
Exchange rate differences     (63 )     112  
2013 Exchange agreement :                
Induced conversion of convertible debt     9,330          
Issuance of warrants     568          
Interest expense (including debt issuance costs)     4,268       1,238  
Change in fair value of warrants, embedded derivatives and anti-dilution rights     64       (1,322 )
    $ 14,177     $ 38